Stay updated on Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial page.

Latest updates to the Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAmyloidosis is now listed as a topic and the Genetic and Rare Diseases Information Center is added as a resource. The site revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a glossary display option; updated page metadata to Revision: v3.4.0 and added the Last Update Submitted that Met QC Criteria label, with capitalization tweaks for No FEAR Act Data.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section updated: added numerous site locations across the United States, Australia, Canada, and several European regions, and removed several previously listed sites.SummaryDifference2%

- Check92 days agoChange DetectedThe Publications note now states that entries are automatically filled from PubMed and may not be about the study. The page revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial page.